secwatch.observer — SEC 8-K summary
======================================

Issuer:     Indaptus Therapeutics, Inc. (INDP)
CIK:        0001857044
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001641172-25-014972
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Indaptus raises $2.3M via convertible notes and warrants; up to $5M total
-------------------------------------------------------------------------

- $2.3M aggregate principal of 6% convertible promissory notes; mature July 28, 2026.
- Conversion at 80% of 5-day VWAP, max $0.40; warrants for 200% of conversion shares after approval.
- Net proceeds for R&D, Phase 1b/2 trial funding, and general working capital.
- Offering may increase to $5M; Paulson Investment Company is exclusive placement agent with 12% fee.
- Company must hold special meeting for stockholder approval; note conversion tied to reverse split or 1 year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/0001641172-25-014972-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014972

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer